Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-02-06
1998-04-07
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
5303919, 530399, 435 691, 435 694, A61F 200, A61K 4700, A61K 31685
Patent
active
057365164
ABSTRACT:
The present invention relates generally to methods for treating injury or degeneration of retinal neurons, and in particular photoreceptors, by administering glial cell line-derived neurotrophic factor (GDNF). The invention relates specifically to methods for treating retinal conditions or diseases in which vision is lost such as retinitis pigmentosa, age-related macular degeneration, diabetic retinopathy, peripheral vitreoretinopathies, photic retinopathies, surgery-induced retinopathies, viral retinopathies, ischemic retinopathies, retinal detachment and traumatic retinopathy.
REFERENCES:
patent: 5641749 (1997-06-01), Yan et al.
patent: 5641750 (1997-06-01), Louis
Amgen Inc.
Curry Daniel R.
Levy Ron K.
Odre Steven M.
Touzeku Phynn
LandOfFree
Methods for treating photoreceptors using glial cell line-derive does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for treating photoreceptors using glial cell line-derive, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for treating photoreceptors using glial cell line-derive will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-13462